Compound Detail
CHEMBL548
DINOPROSTONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL548 |
| Name | DINOPROSTONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XEYBRNLFEZDVAW-ARSRFYASSA-N |
| Therapeutic | ✓ Yes |
16
Targets
76
Activities
3
Assay Types
1
PK Parameters
20
Publications
14
Known Names
5
Indications
1
Mechanisms
Molecular Properties
352.5
MW (Da)
3.25
ALogP
4
HBA
3
HBD
94.8
PSA (Ų)
0.37
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1977 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Prostaglandin E2 receptor agonist | AGONIST | Prostaglandin E2 receptor | ✓ | ✓ |
Indications
Fetal Growth Retardation Myoma Pain Pregnancy Abortion, Incomplete
ATC Classification
G02AD02
dinoprostone
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS
Activity Summary
Ki 34 meas. best 9.96
EC50 21 meas. best 10.7
IC50 21 meas. best 9.49
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prostaglandin E2 receptor EP4 subtype CHEMBL1836 | EC50 | 10.7 | 9.018 | 0.0 | 5 |
| Prostaglandin E2 receptor EP4 subtype CHEMBL1836 | Ki | 9.96 | 9.2733 | 0.1 | 9 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL4909 | EC50 | 9.7 | 8.71 | 0.2 | 2 |
| Prostaglandin E2 receptor EP4 subtype CHEMBL1836 | IC50 | 9.49 | 8.8663 | 0.3 | 8 |
| Prostaglandin E2 receptor EP3 subtype CHEMBL3710 | Ki | 9.48 | 8.98 | 0.3 | 4 |
| Prostaglandin E2 receptor EP4 subtype CHEMBL4086 | EC50 | 9.15 | 8.805 | 0.7 | 2 |
| Prostaglandin E2 receptor EP3 subtype CHEMBL3710 | IC50 | 9.03 | 9.03 | 0.9 | 1 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL1881 | Ki | 8.99 | 8.3517 | 1.0 | 6 |
| Prostaglandin E2 receptor EP1 subtype CHEMBL1811 | IC50 | 8.96 | 8.96 | 1.1 | 1 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL1881 | EC50 | 8.72 | 7.705 | 1.9 | 6 |
| Prostaglandin E2 receptor EP4 subtype CHEMBL4086 | IC50 | 8.68 | 8.68 | 2.1 | 1 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL1881 | IC50 | 8.66 | 8.3567 | 2.2 | 6 |
| Prostaglandin E2 receptor EP3 subtype CHEMBL3710 | EC50 | 8.6 | 8.6 | 2.5 | 1 |
| Prostaglandin E2 receptor EP4 subtype CHEMBL2489 | Ki | 8.51 | 8.51 | 3.1 | 2 |
| Prostaglandin E2 receptor EP1 subtype CHEMBL1811 | EC50 | 8.43 | 8.43 | 3.7 | 1 |
| Prostaglandin E2 receptor EP3 subtype CHEMBL4336 | Ki | 8.3 | 8.3 | 5.0 | 2 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL4909 | IC50 | 8.28 | 8.28 | 5.2 | 1 |
| Prostaglandin E2 receptor EP1 subtype CHEMBL2181 | Ki | 8.22 | 8.22 | 6.0 | 2 |
| Prostaglandin E2 receptor EP1 subtype CHEMBL1811 | Ki | 8.04 | 7.9433 | 9.1 | 3 |
| Unchecked CHEMBL612545 | IC50 | 7.76 | 7.76 | 17.3 | 1 |
| Prostaglandin E2 receptor EP2 subtype CHEMBL2488 | Ki | 7.66 | 7.66 | 22.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 7.05 | 6.965 | 90.0 | 2 |
| Prostaglandin F2-alpha receptor CHEMBL1987 | EC50 | 6.6 | 6.6 | 250.0 | 1 |
| Prostacyclin receptor CHEMBL1995 | IC50 | 6.58 | 6.58 | 260.0 | 1 |
| Prostacyclin receptor CHEMBL1995 | EC50 | 6.46 | 6.46 | 347.0 | 1 |
| Solute carrier family 22 member 6 CHEMBL5653 | Ki | 5.47 | 5.47 | 3388.4 | 2 |
| Solute carrier family 22 member 20 CHEMBL5269 | Ki | 4.75 | 4.745 | 18000.0 | 2 |
| K562 CHEMBL385 | IC50 | 4.2 | 4.2 | 63000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 336.0 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11708917 | 10.1021/jm010264b | Rattus norvegicus | 19 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 410931 | 10.1021/jm00221a036 | No relevant target | 11 |
| 7086833 | 10.1021/jm00347a003 | Rattus norvegicus | 10 |
| 19172146 | 10.1038/nchembio.147 | Danio rerio | 9 |
| - | 10.1039/C6MD00235H | Solute carrier organic anion transporter family member 2B1 | 7 |
| 189028 | 10.1021/jm00211a007 | Unchecked | 6 |
| 2666669 | 10.1021/jm00128a049 | Rattus norvegicus | 5 |
| 21595651 | 10.1111/j.1476-5381.2011.01495.x | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 17553798 | 10.1074/jbc.m703467200 | Solute carrier family 22 member 20 | 3 |
| 23403082 | 10.1016/j.bmcl.2013.01.025 | Prostaglandin E2 receptor EP4 subtype | 3 |
| 6796685 | 10.1021/jm00143a018 | Cavia porcellus | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 30964292 | 10.1021/acs.jmedchem.9b00336 | Prostaglandin E2 receptor EP4 subtype | 3 |
| 6827556 | 10.1021/jm00357a006 | Canis familiaris | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 30964292 | 10.1021/acs.jmedchem.9b00336 | Prostaglandin E2 receptor EP2 subtype | 3 |
| 17553798 | 10.1074/jbc.m703467200 | Solute carrier family 22 member 6 | 3 |
| 2769690 | 10.1021/jm00129a028 | Rattus norvegicus | 3 |
Data from ChEMBL 36 via Core Engine